Dr. Jasmine Yun, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12409 Ventura Ct Ste C, Studio City, CA 91604 Phone: 818-900-6007 Fax: 818-900-6607 |
Gennady Rubinstein, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3959 Laurel Canyon Blvd, Suite F, Studio City, CA 91604 Phone: 818-505-9300 Fax: 818-505-9292 |
News Archive
DexCom, Inc. today reported its unaudited financial results for the quarter ended March 31, 2010.
Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."
The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex to target with a drug since it is also crucial to the healthy functioning of many immune cells in the body, not just B cells gone bad.
Hemangiomas - strawberry-like birthmarks that commonly develop in early infancy - are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing. Since the 1960s, problematic hemangiomas have been treated with corticosteroids such as dexamethasone or prednisone.
› Verified 5 days ago